Skip to main content
HairCited

Minoxidil para Alopecia Androgenética

A

Basado en 191 estudios (19 meta-analyses, 21 RCTs) con 41,495 participantes en total. 159/191 estudios muestran efectos positivos.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Conclusión

Minoxidil is strongly supported by extensive research as an effective option that may help promote hair regrowth in people with androgenetic alopecia.

  • 191 studies with over 41,000 participants — one of the most researched hair loss ingredients
  • 83% of studies show positive effects on hair regrowth and density
  • Both topical and oral forms are supported by meta-analyses and RCTs
  • Recent expert consensus guidelines support its use as a first-line option

Key Study Findings

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo Efecto: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Efecto: None None

Población: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day vs: None Outcome: consensus recommendations for managing pattern hair loss Efecto: None None

Población: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

non-randomized controlled trial n=60 16 weeks Open-label
Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of …
Dose: Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); vs: Placebo Efecto: All groups showed significant decrease in HLSS and increase in hair density post-treatment (p<0.001) p<0.001
Case Reports n=1 Open-label
Plica Neuropathica (Polonica) Secondary to Diffuse Alopecia: A Case Report and Literature Review.
Dose: None vs: None Outcome: None Efecto: None None

Población: 62-year-old female with diffuse alopecia and plica neuropathica

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study vs: Placebo Efecto: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None

Key Statistics

299

Estudios

68291

Participantes

Positive

A

Calificación

Referenced Papers

Journal of the … 2026
Aesthetic plastic surgery 2025 14 citas
Anais brasileiros de … 2025 7 citas
Acta dermato-venereologica 2025 4 citas
European journal of … 2025 3 citas
Australian prescriber 2025 2 citas
Journal of clinical … 2025 1 citas
Nature reviews. Disease … 2025
Archives of dermatological … 2025
Annals of dermatology 2025
International journal of … 2024 39 citas
Indian journal of … 2024 14 citas
Journal of cosmetic … 2024 11 citas
Journal of clinical … 2024 10 citas
Facial plastic surgery … 2024 8 citas
Photodermatology, photoimmunology & … 2024 8 citas
American family physician 2024 8 citas
Skin health and … 2024 7 citas
International journal of … 2024 5 citas
SAGE open medical … 2024 3 citas
Vestnik oftalmologii 2024 1 citas
Drugs 2023 221 citas
JAAD international 2023 80 citas
Clinical, cosmetic and … 2023 58 citas
American journal of … 2023 41 citas
Anais brasileiros de … 2023 29 citas
Skin appendage disorders 2023 27 citas
Archives of dermatological … 2023 16 citas
Journal der Deutschen … 2023 5 citas
Journal of cosmetic … 2023 3 citas
BMJ case reports 2023 2 citas
Clinics in plastic … 2023 1 citas
International journal of … 2023 1 citas
The Journal of … 2022 170 citas
Faculty reviews 2022 44 citas
Dermatologic therapy 2022 41 citas
Journal of cosmetic … 2022 35 citas
Journal of cosmetic … 2022 7 citas
Facial plastic surgery … 2022
Journal of cutaneous … 2021 44 citas
Journal of the … 2021 42 citas
Actas dermo-sifiliograficas 2021 3 citas
Expert opinion on … 2020 147 citas
International journal of … 2020 58 citas
Indian dermatology online … 2020 31 citas
Dermatologic clinics 2020 15 citas
Facial plastic surgery … 2020 15 citas
Alternative therapies in … 2020 11 citas
Drug design, development … 2019 320 citas
Journal of cosmetic … 2019 100 citas
American journal of … 2019 84 citas
Expert opinion on … 2019 34 citas
Bioscience, biotechnology, and … 2019 9 citas
Journal of the … 2018 114 citas
Indian journal of … 2018 79 citas
Dermatologic therapy 2018 63 citas
Australian journal of … 2018 8 citas
American family physician 2017 141 citas
JAMA dermatology 2017 121 citas
Current clinical pharmacology 2017 62 citas
Actas dermo-sifiliograficas 2017 17 citas
BMJ case reports 2017 6 citas
Deutsches Arzteblatt international 2016 99 citas
The Cochrane database … 2016 18 citas
Current problems in … 2015 8 citas
Der Internist 2015
Expert opinion on … 2014 57 citas
Skin therapy letter 2014 29 citas
Giornale italiano di … 2014 8 citas
Giornale italiano di … 2014
Indian journal of … 2013 196 citas
Dermatologic clinics 2013 78 citas
Journal of cosmetic … 2013 62 citas
International journal of … 2013 61 citas
Indian journal of … 2013 16 citas
Facial plastic surgery … 2013 16 citas
International journal of … 2013
The Cochrane database … 2012 15 citas
Expert opinion on … 2010 264 citas
Current opinion in … 2009 54 citas
Seminars in cutaneous … 2009 4 citas
American family physician 2009
Current opinion in … 2008 31 citas
Nihon rinsho. Japanese … 2008 6 citas
Endocrinology and metabolism … 2007 33 citas
Clinical interventions in … 2007
Acta dermatovenerologica Alpina, … 2005
Annual review of … 2004 664 citas
Revue medicale de … 2004
The journal of … 2003 102 citas
Praxis 2003 28 citas
American family physician 2003 2 citas
American family physician 2003
Clinical and experimental … 2002 61 citas
Therapeutische Umschau. Revue … 2002 4 citas
American journal of … 2000 18 citas
Southern medical journal 2000
International journal of … 1999 16 citas
Journal of cutaneous … 1999
Journal of the … 1999
International journal of … 1999
American family physician 1999
Dermatologic clinics 1998 121 citas
Annales de dermatologie … 1997
Journal of the … 1984

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

topical:
2-5% solution, twice daily

Límite superior: 5% topical solution

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); 16 weeks Positive 60
None -- Mixed 1
varies by agent and study -- Positive --
None -- Positive --
None -- Mixed --

Mejor momento para tomar: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Efectos secundarios reportados

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Interacciones conocidas

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Ingesta máxima tolerable: 5% topical solution

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Minoxidil help with Alopecia Androgenética?
Based on 299 studies with 68,291 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Alopecia Androgenética management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Alopecia Androgenética?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Alopecia Androgenética?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 299 peer-reviewed studies with 68,291 total participants. The overall direction of effect is positive.

Related Evidence

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.